CYCLIN-DEPENDENT KINASE INHIBITOR, PALBOCICLIB - A NEW DRUG FOR THE TREATMENT OF METASTATIC BREAST CANCER
The sequential use of several lines of endocrine therapy is considered the standard for the treatment of metastatic breast cancer, expressing estrogen or progesterone receptors. PALOMA-1, -2 and -3 studies showed that the combination of the inhibitor of CDK4/6, palbociclib, with endocrine therapy si...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
ABV-press,
2017-12-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |